THERAPEUTIC APPROACHES IN PREVENTING THE PROGRESSION OF ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

• Autor(a) principal: Oliveira, Gabriela Cruz de
• Data de Publicação: 2024
• Outros Autores: Bessa, Nathalia Sbampato Mol, Haddad, Lucas Oliveira Dabien, Assunção, Cleaide Ataíde Lima, Assuncao Júnior, José Lima, Albuquerque , Áurea Amélia Coutinho Nogueira de, Paysano, Maria Lúcia Brito de Araujo, Gouveia, Pietro Brandão, Cruz, Juliana Gomes, Cavalcante , Rômulo Basílio Ferro Gomes, Coímbra , Igor Bonifácio Andrade, Rapette , Fiama Jéssica Francieli Cardoso, Morais, Júlia Rodna Gomes Paiva Arcanjo de, Martins, Vitoria Roriz, Neves, Sara Izabel Cargnin Henrique, Ferreira , Laís Jaciara Costa Revil, Ramos, Isabela Costa, Miguez, Juliana Pinho, Cerqueira jr , Vanilson Pires, Barbosa , Matheus Fonseca, Vieira , Izadora Carneiro, Reis, Davi Bayma, Pereira, Narjara Samya Rodrigues, Giácomo, Brenda Santana Araujo, Fé Filho, Rogério Lopes de Moura
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/1480
• topic: Alzheimer. Abordagens terapêuticas. Prevenção.; Alzheimer's. Therapeutic approaches. Prevention.

The therapeutic approach to AD is constantly evolving, ranging from pharmacological advances to innovative strategies aimed at improving neuroplasticity. This diversity of therapeutic options reflects an ongoing effort to offer more effective and comprehensive treatments for those affected by AD, highlighting the importance of continuously developing therapeutic strategies in this challenging scenario. The aim of this study was to identify therapeutic approaches aimed at preventing the progression of Alzheimer's disease. A systematic literature review was carried out using the Scielo, Lilacs and Medline databases. In conclusion, therapeutic approaches to Alzheimer's disease are diverse and constantly evolving. Although there have been promising advances, especially in pharmacological strategies such as the use of monoclonal antibodies, gene therapy and nanotechnology, challenges remain, including variation in the effectiveness of specific treatments and the ongoing need to assess potential long-term adverse effects.